Efficacy and safety of the glycine transporter type-1 inhibitor AMG 747 for the treatment of negative symptoms associated with schizophrenia.

Dunayevich, Eduardo; Buchanan, Robert W; Chen, Chao-Yin; Yang, Jun; Nilsen, Jon; Dietrich, Julie M; Sun, Hong; Marder, Stephen.
Schizophr Res; 182: 90-97, 2017 04.
Artigo em Inglês | MEDLINE | ID: mdl-27789188